Locust Wood Capital Advisers Raised Cisco Sys (CSCO) Position; Insmed Has 3.74 Sentiment

January 6, 2018 - By Clifton Ray

Insmed Incorporated, a biopharmaceutical company, focuses on the development and commercialization of therapies for patients with rare diseases. The company has market cap of $2.26 billion. The companyÂ’s lead product candidate is ARIKAYCE or liposomal amikacin for inhalation, a formulation of amikacin that is in late-stage clinical development for adult patients with treatment refractory nontuberculous mycobacteria lung disease caused by Mycobacterium avium complex. It currently has negative earnings. It is also developing INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1, which has completed a Phase I clinical study for activating neutrophil serine proteases that are implicated in the pathology of chronic inflammatory lung diseases, such as non-cystic fibrosis bronchiectasis; and INS1009, an inhaled nanoparticle formulation of a treprostinil prodrug, which has completed a Phase I clinical study for treating rare pulmonary disorders, including pulmonary arterial hypertension.

Locust Wood Capital Advisers Llc increased Cisco Sys Inc (CSCO) stake by 15.73% reported in 2017Q3 SEC filing. Locust Wood Capital Advisers Llc acquired 158,179 shares as Cisco Sys Inc (CSCO)’s stock declined 7.50%. The Locust Wood Capital Advisers Llc holds 1.16 million shares with $39.15 million value, up from 1.01M last quarter. Cisco Sys Inc now has $195.42 billion valuation. The stock increased 1.38% or $0.54 during the last trading session, reaching $39.53. About 24.59 million shares traded or 26.82% up from the average. Cisco Systems, Inc. (NASDAQ:CSCO) has risen 13.20% since January 6, 2017 and is uptrending. It has underperformed by 3.50% the S&P500.

Investors sentiment decreased to 1.02 in Q3 2017. Its down 0.16, from 1.18 in 2017Q2. It is negative, as 74 investors sold CSCO shares while 637 reduced holdings. 107 funds opened positions while 619 raised stakes. 3.60 billion shares or 0.03% more from 3.60 billion shares in 2017Q2 were reported. Wellington Shields Ltd stated it has 42,174 shares. Breton Hill Capital accumulated 98,717 shares. The Pennsylvania-based Haverford Financial Serv has invested 0.1% in Cisco Systems, Inc. (NASDAQ:CSCO). First Fiduciary Counsel reported 4.32% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO). Hillsdale Investment Mgmt invested 0.05% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO). Allsquare Wealth Mgmt Ltd Liability Co stated it has 650 shares or 0.02% of all its holdings. The California-based Wells Fargo Communication Mn has invested 0.65% in Cisco Systems, Inc. (NASDAQ:CSCO). Highvista Strategies Ltd Liability Corporation stated it has 17,028 shares or 0.13% of all its holdings. Ruffer Ltd Liability Partnership stated it has 102,830 shares. 144,626 are held by Folger Nolan Fleming Douglas Cap Management Incorporated. Howard Capital Mgmt has 0.16% invested in Cisco Systems, Inc. (NASDAQ:CSCO). Investec Asset Management Limited has 0.1% invested in Cisco Systems, Inc. (NASDAQ:CSCO) for 688,386 shares. Bb&T Corp has invested 0.88% in Cisco Systems, Inc. (NASDAQ:CSCO). Cibc Bancorp Usa holds 0.13% in Cisco Systems, Inc. (NASDAQ:CSCO) or 29,287 shares. Montecito Bank & Trust Tru stated it has 20,837 shares.

Among 37 analysts covering Cisco Systems Inc. (NASDAQ:CSCO), 24 have Buy rating, 0 Sell and 13 Hold. Therefore 65% are positive. Cisco Systems Inc. had 133 analyst reports since August 4, 2015 according to SRatingsIntel. The stock has “Buy” rating by Wells Fargo on Friday, July 21. As per Thursday, August 17, the company rating was maintained by Robert W. Baird. On Thursday, May 19 the stock rating was maintained by Credit Suisse with “Underperform”. The stock has “Outperform” rating by RBC Capital Markets on Thursday, February 16. Jefferies maintained the shares of CSCO in report on Tuesday, September 5 with “Buy” rating. The firm has “Buy” rating given on Thursday, June 29 by Robert W. Baird. The firm has “Hold” rating by Nomura given on Wednesday, June 21. On Wednesday, November 15 the stock rating was maintained by BMO Capital Markets with “Hold”. William Blair maintained the stock with “Buy” rating in Thursday, June 29 report. Bernstein maintained the stock with “Buy” rating in Thursday, June 29 report.

Since August 23, 2017, it had 0 insider buys, and 7 selling transactions for $23.51 million activity. $3.89 million worth of Cisco Systems, Inc. (NASDAQ:CSCO) was sold by Robbins Charles. The insider MCGEARY RODERICK C sold $578,740. Another trade for 23,110 shares valued at $740,883 was made by Walker Karen on Monday, September 11. $7.59 million worth of stock was sold by BARTZ CAROL on Thursday, December 14. Another trade for 25,638 shares valued at $821,900 was made by BHATT PRAT on Monday, September 11. CHANDLER MARK D sold 65,000 shares worth $2.11M. 250,000 shares valued at $7.79 million were sold by CHAMBERS JOHN T on Wednesday, August 23.

Locust Wood Capital Advisers Llc decreased Silver Run Acquisition stake by 1.10M shares to 12,805 valued at $137,000 in 2017Q3. It also reduced Liberty Broadband Corp stake by 141,475 shares and now owns 205,692 shares. Commercehub Inc was reduced too.

Analysts await Insmed Incorporated (NASDAQ:INSM) to report earnings on February, 22. They expect $-0.66 earnings per share, up 40.00% or $0.44 from last year’s $-1.1 per share. After $-0.69 actual earnings per share reported by Insmed Incorporated for the previous quarter, Wall Street now forecasts -4.35% EPS growth.

Since January 1, 0001, it had 0 insider purchases, and 2 selling transactions for $2.70 million activity.

Palo Alto Investors Llc holds 8.11% of its portfolio in Insmed Incorporated for 6.17 million shares. Foresite Capital Management Ii Llc owns 300,000 shares or 3.8% of their US portfolio. Moreover, Redmile Group Llc has 3.07% invested in the company for 1.99 million shares. The New York-based Ghost Tree Capital Llc has invested 2.15% in the stock. Ra Capital Management Llc, a Massachusetts-based fund reported 722,714 shares.

The stock decreased 3.12% or $0.95 during the last trading session, reaching $29.51. About 626,262 shares traded. Insmed Incorporated (INSM) has risen 57.88% since January 6, 2017 and is uptrending. It has outperformed by 41.18% the S&P500.